Drug Shortage Report for TEVA-TRIAMTERENE/HCTZ
| Report ID | 110794 |
| Drug Identification Number | 00532657 |
| Brand name | TEVA-TRIAMTERENE/HCTZ |
| Common or Proper name | TEVA-TRIAMTERENE HCTZ 50/25MG TABS |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | TRIAMTERENE HYDROCHLOROTHIAZIDE |
| Strength(s) | 50MG 25MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 500's |
| ATC code | C03EA |
| ATC description | DIURETICS AND POTASSIUM-SPARING AGENTS IN COMB |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2020-04-01 |
| Estimated end date | |
| Actual end date | 2020-05-08 |
| Shortage status | Resolved |
| Updated date | 2020-05-14 |
| Company comments | Item is discontinued |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2020-05-14 | French | Compare |
| v3 | 2020-05-14 | English | Compare |
| v2 | 2020-04-03 | French | Compare |
| v1 | 2020-04-03 | English | Compare |
Showing 1 to 4 of 4